ESCMID Study Group for host and microbiota interaction – ESGHAMI

 

ESGHAMI Annual Report

Download the latest Annual Report.

News & Activities


Parkinson disease and the role of the gut microbiome

Webinar organized by ESGHAMI on October 19th, 2022; 4.30-5.30 pm

 

Parkinson’s disease (PD) is characterized by the degeneration of neurons and the presence of Lewy bodies and Lewy neuritis in the central nervous system, enteric nervous system and peripheral autonomic nervous system. The etiology and pathogenesis of PD is still largely unknown, although a role for the aggregation of alpha-synuclein (αSyn) is generally acknowledged. Gastro-intestinal symptoms are frequently observed in PD patients and often precede the onset of motor symptoms. This led to the hypothesis that the disease may start in the gut, with misfolded αSyn fragments being transported to the CNS through the vagal nerve. This webinar will  provide an overview on the current knowledge of the gut microbiome in PD and its interventions to influence the cours of te disease.   

 

Chairs: dr. Fiorella Contarino and prof. dr Ed J. Kuijper

 

1. Introduction; who, when and what of Parkinson Disease (10 min)

 

Dr. Fiorella Contarino;  Department of Neurology, Leiden University Medical Cntre,  Leiden, The Netherlands

 

2. Evidence for microbiome alterations in Parkinson’s disease (20 min)

 

Dr. Falk Hildebrand;   Quadram Institute Bioscience & Earlham Institute,  Norwich Research Park, UK

 

3. Parkinson Disease and microbiota interventions as treatment option  (20 min )

 

Drs. Vlada Chernova; Netherlands Donor Feces Bank and Dept. of Neurology, Leiden University Medical Cntre,  Leiden, The Netherlands

 

 

 

The webinar will be organised with support of ESCMID using the following Zoom link:    

 

https://escmid-org.zoom.us/j/81894749890?pwd=d1gvZVIyeGdDcmpFM00xZ3ZJMUhYUT09

 

2021 Annual Report Published

The Annual Report showcasing the achievements of the previous year is now available to view. Be sure to check out the report to see what the Study Group was able to accomplish in 2021 as well as what they plan for the future.

New ESGHAMI Executive Committee elected

A new ESGHAMI Executive Committee has been elected and will now be:

  • Ed J. Kuijper, Netherlands (Chair)
  • Debby Bogaert, United Kingdom (Treasurer)
  • Maria Vehreschild, Germany (Secretary)

We thank all previous Executive Committee for their excellent work over the last years. We are looking forward to continuing this work.

You can find the full election report here

International Conference on One Health Antimicrobial Resistance (ICOHAR

Co-organised by ESGVM, ESGHAMI, the University of Copenhagen, the European Association of Veterinary Pharmacology and Toxicology (EAVPT), the network Edinburgh Infectious Diseases (EID), the Netherlands Center for One Health, the World Small Animal Veterinary Association (WSAVA)

16 – 18 April 2019, Copenhagen, Denmark

It is generally recognized that control and prevention of antimicrobial resistance (AMR) requires a holistic One Health approach involving specialists from different sectors. In line with this concept, the 2nd ICOHAR aims at bringing together representatives from all relevant sectors (e.g. public health, human and veterinary medicine, livestock production, food safety and environmental sciences) to share research and education strategies for understanding and reducing the risks of AMR at the interphase between humans, animals and the environment. The programme does not only focus on zoonotic transfer of AMR but also on the numerous AMR-related challenges shared by clinicians, clinical microbiologists, infectious disease specialists and researchers working in these sectors.

Read more

ESCMID study group for host and microbiota interaction group: ESGHAMI

October 19, 2018

In 2018, ESCMID approved a new study group (SG) for studying host-microbiota interactions. The overall aim of this new SG is to bridge diagnostic, clinical and scientific specialties across the relatively new field of microbiota research in Europe. Microbiota research concerned will cover intestinal, urogenital, respiratory and skin microbiota of both humans and animals and will include studies on the interactions of microbiota with the host immune response. The central theme will be focused on clinical significance of and therapeutic interventions on host-microbiota associated diseases and health.

 

We are especially looking for 1) members who are interested to contribute in Horizon 2020 & ESCMID research funding to apply for funding on microbiota research and 2) members who want to contribute in a review article for publication in CMI on our future position. However, every scientist/physician with interest in microbiota is welcome!

 

On behalf of prof. dr Benoit Guery (secretary) and prof. dr. Maria Vehreschild (treasurer)”

 

Prof. dr. Ed J. Kuijper, chair,  Department of Medical Microbiology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden.

Phone; +31-71-5363574

Email: e.j.kuijper[at]lumc.nl.